hydroxyurea has been researched along with Actinic Keratosis in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, these agents also place patients at increased risk for drug-related cutaneous adverse events." | 2.66 | Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review. ( Guglielmelli, P; Malato, A; Palumbo, GA; Pugliese, N; Rossi, E, 2020) |
| " However, no epidemiologic information about the occurrence of the most clinically significant HU-associated adverse events is yet available." | 1.38 | Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN. ( Antonioli, E; Baccarani, M; Barbui, T; Bertozzi, I; Bosi, A; Cacciola, E; Cacciola, R; Cazzola, M; De Stefano, V; Elli, E; Finazzi, G; Finazzi, M; Guglielmelli, P; Luigia Randi, M; Martinelli, V; Passamonti, F; Pieri, L; Pogliani, E; Rambaldi, A; Rodeghiero, F; Rossi, E; Ruggeri, M; Rumi, E; Vannucchi, AM; Vianelli, N; Za, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Romagnuolo, M | 1 |
| Riva, D | 1 |
| Alberti Violetti, S | 1 |
| Di Benedetto, A | 1 |
| Barberi, F | 1 |
| Moltrasio, C | 1 |
| Song, Z | 1 |
| Chu, S | 1 |
| Tao, J | 1 |
| Qian, Y | 1 |
| Malato, A | 1 |
| Rossi, E | 2 |
| Palumbo, GA | 1 |
| Guglielmelli, P | 2 |
| Pugliese, N | 1 |
| Koch, L | 1 |
| Lichem, R | 1 |
| Cerroni, L | 1 |
| Aberer, W | 1 |
| Massone, C | 1 |
| Mokni, S | 1 |
| Fetoui Ghariani, N | 1 |
| Aounallah, A | 1 |
| Fathallah, N | 1 |
| Boussofara, L | 1 |
| Saidi, W | 1 |
| Ben Salem, C | 1 |
| Sriha, B | 1 |
| Belajouza, C | 1 |
| Denguezli, M | 1 |
| Ghariani, N | 1 |
| Nouira, R | 1 |
| Schleußinger, TM | 1 |
| Dyall-Smith, D | 1 |
| Field, LM | 1 |
| Antonioli, E | 1 |
| Pieri, L | 1 |
| Finazzi, M | 1 |
| Rumi, E | 1 |
| Martinelli, V | 1 |
| Vianelli, N | 1 |
| Luigia Randi, M | 1 |
| Bertozzi, I | 1 |
| De Stefano, V | 1 |
| Za, T | 1 |
| Ruggeri, M | 1 |
| Elli, E | 1 |
| Cacciola, R | 1 |
| Cacciola, E | 1 |
| Pogliani, E | 1 |
| Rodeghiero, F | 1 |
| Baccarani, M | 1 |
| Passamonti, F | 1 |
| Finazzi, G | 1 |
| Rambaldi, A | 1 |
| Bosi, A | 1 |
| Cazzola, M | 1 |
| Barbui, T | 1 |
| Vannucchi, AM | 1 |
1 review available for hydroxyurea and Actinic Keratosis
| Article | Year |
|---|---|
Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review.
Topics: Humans; Hydroxyurea; Interferons; Janus Kinase Inhibitors; Keratosis, Actinic; Myeloproliferative Di | 2020 |
6 other studies available for hydroxyurea and Actinic Keratosis
| Article | Year |
|---|---|
Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report.
Topics: Female; Humans; Hydroxyurea; Keratosis, Actinic; Porokeratosis; Ultraviolet Rays | 2023 |
Successful management of hydroxyurea-induced multiple actinic keratoses and cutaneous squamous cell carcinomas with combination treatment.
Topics: Carcinoma, Squamous Cell; Humans; Hydroxyurea; Keratosis, Actinic; Skin Neoplasms | 2023 |
Dermatitis, nonmelanoma skin cancer and leg ulcers.
Topics: Aged, 80 and over; Antineoplastic Agents; Dermatomyositis; Female; Humans; Hydroxyurea; Keratosis, A | 2016 |
[Dermatologic complications of long-term hydroxyurea therapy].
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Hydroxyurea; Keratosis, Actinic; Male; Midd | 2017 |
Hydroxyurea-associated squamous dysplasia in a monozygotic twin.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Diseases in Twins; Facial Dermatoses; Female; Hand Derm | 2011 |
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Carcinoma, Squamous Cell; Drug Eruptions; Female; F | 2012 |